Patrick Plewman
SVP for Diagnostic Services at Quest Diagnostics Inc (DGX) since November 2022
Patrick Plewman has filed 37 insider reports with the SEC since November 2022, as SVP for Diagnostic Services at Quest Diagnostics Inc (DGX). In the last 12 months Patrick Plewman sold $5.04M of stock on the open market. In the latest filing, on November 13, 2026, Patrick Plewman sold 11,717 shares of Quest Diagnostics Inc (DGX) for $3.02M at an average of $257.34.
- Filings
- 37
- Companies
- 1
- Bought on market
- None
- Sold on market
- $7.61M
Companies where Patrick Plewman is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| SVP for Diagnostic Servicessince November 2022 | 14,684 | $7.61M | $259.69 | Nov 13, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 9, 2026-$3.02MDGXSVP for Diagnostic Services Plewman Patrick exercised 11,067 shares at a strike of $127.77 and sold $3,015,253 worth of shares (11,717 units at $257.34) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 14,684 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jul 22, 2026DGXSVP for Diagnostic Services Plewman Patrick increased direct ownership by 0.30% to 15,293 unitsForm 4Small acquisition
- Apr 20, 2026DGXSVP for Diagnostic Services Plewman Patrick increased direct ownership by 0.32% to 15,247 unitsForm 4Small acquisition
- Mar 5, 2026-$589KDGXSVP for Diagnostic Services Plewman Patrick sold $588,730 worth of shares (2,855 units at $206.21), was granted 5,682 shares and covered exercise/tax liability with 2,827 sharesForm 4Grant or awardShares withheld for taxes or exercise priceOpen-market sale10b5-1 plan
- Mar 3, 2026-$85.2KDGXSVP for Diagnostic Services Plewman Patrick covered exercise/tax liability with 230 shares and sold $85,169 worth of shares (410 units at $207.73), decreasing direct ownership by 4% to 15,198 unitsForm 4Shares withheld for taxes or exercise priceOpen-market sale10b5-1 plan
- Feb 19, 2026-$196KDGXSVP for Diagnostic Services Plewman Patrick covered exercise/tax liability with 537 shares, sold $196,227 worth of shares (958 units at $204.83) and was granted 1,952 shares, increasing direct ownership by 3% to 15,838 unitsForm 4Grant or awardShares withheld for taxes or exercise priceOpen-market sale10b5-1 plan
- Feb 10, 2026-$1.16MDGXSVP for Diagnostic Services Plewman Patrick sold $1,155,048 worth of shares (5,662 units at $204.00), was granted 48 shares and exercised 5,662 shares at a strike of $121.81, increasing direct ownership by 0.31% to 15,381 unitsForm 4Grant or awardExercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Oct 21, 2025DGXSVP for Diagnostic Services Plewman Patrick was granted 46 shares, increasing direct ownership by 0.30% to 15,333 unitsForm 4Grant or award
- Aug 21, 2025-$365KDGXSVP for Diagnostic Services Plewman Patrick sold $365,375 worth of shares (1,975 units at $185.00), decreasing direct ownership by 11% to 15,269 unitsForm 4Open-market sale10b5-1 plan
- Aug 19, 2025-$829KDGXSVP for Diagnostic Services Plewman Patrick exercised 4,532 shares at a strike of $112.17 and sold $829,356 worth of shares (4,532 units at $183.00)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 21, 2025~$365KDGXPatrick Plewman plans to sell 1,975 shares (~$365K)Form 144Planned sale10b5-1 plan
- Aug 15, 2025-$356KDGXSVP for Diagnostic Services Plewman Patrick sold $355,500 worth of shares (1,975 units at $180.00), decreasing direct ownership by 10% to 17,244 unitsForm 4Open-market sale10b5-1 plan
- Aug 6, 2025-$969KDGXSVP for Diagnostic Services Plewman Patrick sold $968,625 worth of shares (5,535 units at $175.00) and exercised 3,560 shares at a strike of $86.63, decreasing direct ownership by 9% to 19,219 unitsForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jul 21, 2025DGXSVP for Diagnostic Services Plewman Patrick increased direct ownership by 0.38% to 21,185 unitsForm 4Small acquisition
- Apr 21, 2025DGXSVP for Diagnostic Services Plewman Patrick increased direct ownership by 0.39% to 21,087 unitsForm 4Small acquisition
- Mar 26, 2025DGXSVP for Diagnostic Services Plewman Patrick covered exercise/tax liability with 162 shares, decreasing direct ownership by 0.77% to 20,988 unitsForm 4Shares withheld for taxes or exercise price
- Mar 4, 2025DGXSVP for Diagnostic Services Plewman Patrick was granted 5,674 shares and covered exercise/tax liability with 2,386 shares, increasing direct ownership by 18% to 21,150 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Feb 26, 2025DGXSVP for Diagnostic Services Plewman Patrick covered exercise/tax liability with 229 shares, decreasing direct ownership by 1% to 17,853 unitsForm 4Shares withheld for taxes or exercise price
- Feb 19, 2025-$54.3KDGXSVP for Diagnostic Services Plewman Patrick sold $54,307 worth of shares (320 units at $169.71), decreasing direct ownership by 2% to 18,082 unitsForm 4Open-market sale
- Feb 12, 2025DGXSVP for Diagnostic Services Plewman Patrick was granted 2,042 shares, increasing direct ownership by 12% to 18,402 unitsForm 4Grant or award
- Jan 29, 2025DGXSVP for Diagnostic Services Plewman Patrick increased direct ownership by 0.35% to 16,345 unitsForm 4Small acquisition
- Oct 21, 2024DGXSVP for Diagnostic Services Plewman Patrick increased direct ownership by 0.37% to 16,258 unitsForm 4Small acquisition
- Jul 22, 2024DGXSVP for Diagnostic Services Plewman Patrick increased direct ownership by 0.37% to 16,162 unitsForm 4Small acquisition
- Apr 22, 2024DGXPlewman Patrick was granted 69 shares, increasing direct ownership by 0.43% to 16,062 unitsForm 4Grant or award
- Mar 26, 2024DGXPlewman Patrick covered exercise/tax liability with 114 shares, decreasing direct ownership by 0.71% to 15,981 unitsForm 4Shares withheld for taxes or exercise price
- Feb 28, 2024DGXPlewman Patrick covered exercise/tax liability with 333 shares, decreasing direct ownership by 2% to 16,082 unitsForm 4Shares withheld for taxes or exercise price
- Feb 23, 2024DGXPlewman Patrick was granted 2,388 shares and covered exercise/tax liability with 869 shares, increasing direct ownership by 10% to 16,415 unitsForm 4Grant or awardShares withheld for taxes or exercise price
- Feb 21, 2024DGXPlewman Patrick covered exercise/tax liability with 139 shares, decreasing direct ownership by 0.92% to 14,896 unitsForm 4Shares withheld for taxes or exercise price
- Feb 14, 2024DGXPlewman Patrick was granted 2,446 shares, increasing direct ownership by 19% to 15,035 unitsForm 4Grant or award
- Jan 31, 2024DGXPlewman Patrick was granted 50 shares, increasing direct ownership by 0.40% to 12,589 unitsForm 4Grant or award
- Jul 25, 2023DGXSEC Form 4 filed by Plewman PatrickForm 4Grant or award
- Apr 24, 2023DGXSEC Form 4 filed by Plewman PatrickForm 4Small acquisition
- Mar 24, 2023DGXSEC Form 4 filed by Plewman PatrickForm 4Shares withheld for taxes or exercise price
- Mar 6, 2023DGXSEC Form 4: Plewman Patrick was granted 2,579 shares and covered exercise/tax liability with 799 shares, increasing direct ownership by 17% to 12,357 units (tax liability)Form 4Grant or awardShares withheld for taxes or exercise price
- Feb 23, 2023DGXSEC Form 4: Plewman Patrick covered exercise/tax liability with 245 shares and was granted 1,919 shares, increasing direct ownership by 19% to 10,656 units (tax withholding)Form 4Grant or awardShares withheld for taxes or exercise price
- Feb 1, 2023DGXSEC Form 4: Plewman Patrick increased direct ownership by 0.30% to 8,982 unitsForm 4Small acquisition
- Nov 16, 2022DGXSEC Form 3: New insider Plewman Patrick claimed ownership of 8,924 sharesForm 3New insider
Compare Patrick Plewman with
- Patrick Plewman vs Michael J Deppe1 shared
- Patrick Plewman vs Subu Ramachandran1 shared
- Patrick Plewman vs Catherine T. Doherty1 shared
- Patrick Plewman vs Mark E Delaney1 shared
- Patrick Plewman vs Timothy C Wentworth1 shared
- Patrick Plewman vs J. E. Davis1 shared
Other insiders at the same companies
- Michael J DeppeDGX
- Subu RamachandranDGX
- Catherine T. DohertyDGX
- Mark E DelaneyDGX
- Timothy C WentworthDGX
- J. E. DavisDGX
- Michael E PrevoznikDGX
- Karthik KuppusamyDGX
- Robert B CarterDGX
- Vicky B GreggDGX
- Timothy L MainDGX
- Sam SamadDGX
- Wright Lassiter IIIDGX
- Luis DiazDGX
- Tracey DoiDGX
- Timothy M RingDGX
Questions about Patrick Plewman
- What is Patrick Plewman's role at Quest Diagnostics Inc?
- Patrick Plewman reports to the SEC as SVP for Diagnostic Services at Quest Diagnostics Inc (DGX), according to the latest filing on November 13, 2026.
- How many shares does Patrick Plewman own?
- After the latest filing that states it, Patrick Plewman directly owned 14,684 shares of Quest Diagnostics Inc (DGX). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Patrick Plewman bought or sold stock recently?
- The most recent open-market sale was on November 9, 2026: sold 11,717 shares of Quest Diagnostics Inc (DGX) for $3.02M at an average of $257.34.
- How do I get alerts when Patrick Plewman files?
- Follow Patrick Plewman on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Patrick Plewman filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Patrick Plewman (SEC CIK 0001497368). Totals count each trade once, skipping amendments whose original is on file, from Nov 22, 2022 on. View on SEC EDGAR